AKT1 and glioma: BAS-4 additionally reduced the expression of the protein kinase B/Akt signaling pathway, which is activated in glioma cells, demonstrating its effectiveness with low cytotoxic activity in non-neoplastic cells and a low hemolytic index in red blood cells.